Shift in epitope dominance of IgM and IgG responses to Plasmodium falciparum MSP1 block 4

Sandra P Chang1, Alexander K K Kayatani, Zilka I Terrientes

  • 1John A Burns School of Medicine, University of Hawaii at Manoa, 651 Ilalo St, Honolulu, HI 96813, USA. sandrac@hawaii.edu

Malaria Journal
|January 15, 2010
PubMed
Abstract

Insights

Immune responses to Plasmodium falciparum merozoite surface protein-1 (MSP1) block 4 were studied in diverse populations. Antibodies to MSP1 block 4 indicate its potential role in isolate-specific immunity to malaria.

Area of Science:

  • Immunology
  • Malariology
  • Genetics

Background:

  • Plasmodium falciparum merozoite surface protein-1 (MSP1) is a key malaria vaccine candidate.
  • Focus has been on MSP1 C-terminal regions (blocks 16-17) and N-terminal repeats (block 2).
  • Emerging evidence suggests other MSP1 regions, like block 4, are under immune selection.

Purpose of the Study:

  • To investigate antibody responses to MSP1 block 4.
  • To compare responses to block 4 with known regions (blocks 16-17).
  • To analyze responses across populations with varying malaria transmission and ethnicity.

Main Methods:

  • Examined IgM and IgG antibody responses.
  • Utilized parental and recombinant forms of MSP1 block 4 peptides.
  • Included study populations from Colombia, Papua New Guinea, and Cameroon.
  • Compared responses to blocks 16-17 (3D7).

Main Results:

  • IgM and IgG antibodies to MSP1 block 4 were detected in all populations.
  • IgG seropositivity to block 4 varied (15-65%) and was lower than to blocks 16-17.
  • Antibodies to block 4 showed a bias towards IgG3, while blocks 16-17 favored IgG1.

Conclusions:

  • Antibody production to MSP1 block 4 alleles suggests balancing selection by the immune system.
  • MSP1 block 4 may contribute to isolate-specific immunity against Plasmodium falciparum.
  • Immune responses to block 4 are consistent across low and high malaria transmission areas.